AU3788899A - Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery - Google Patents

Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery Download PDF

Info

Publication number
AU3788899A
AU3788899A AU37888/99A AU3788899A AU3788899A AU 3788899 A AU3788899 A AU 3788899A AU 37888/99 A AU37888/99 A AU 37888/99A AU 3788899 A AU3788899 A AU 3788899A AU 3788899 A AU3788899 A AU 3788899A
Authority
AU
Australia
Prior art keywords
cell
ifna2
seq
nucleic acid
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37888/99A
Other languages
English (en)
Inventor
Michael W Heartlein
Richard F. Selden
Douglas A. Treco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Human Genetics Therapies Inc
Original Assignee
Transkaryotic Therapies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transkaryotic Therapies Inc filed Critical Transkaryotic Therapies Inc
Publication of AU3788899A publication Critical patent/AU3788899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU37888/99A 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery Abandoned AU3788899A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8464898P 1998-05-07 1998-05-07
US60084648 1998-05-07
US8655598P 1998-05-21 1998-05-21
US60086555 1998-05-21
PCT/US1999/009925 WO1999057292A1 (en) 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery

Publications (1)

Publication Number Publication Date
AU3788899A true AU3788899A (en) 1999-11-23

Family

ID=26771248

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37888/99A Abandoned AU3788899A (en) 1998-05-07 1999-05-05 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery

Country Status (14)

Country Link
EP (1) EP1075531A1 (tr)
JP (1) JP2002513580A (tr)
KR (1) KR20010052278A (tr)
CN (1) CN1309710A (tr)
AR (1) AR016264A1 (tr)
AU (1) AU3788899A (tr)
CA (1) CA2328459A1 (tr)
CZ (1) CZ299418B6 (tr)
HU (1) HUP0102517A3 (tr)
IL (1) IL139433A0 (tr)
NO (1) NO20005585L (tr)
PL (1) PL344517A1 (tr)
TR (1) TR200003271T2 (tr)
WO (1) WO1999057292A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042442A2 (en) 1999-12-10 2001-06-14 Cytos Biotechnology Ag Activation of endogenous genes by genomic introduction of a replicon
FR2817559B1 (fr) * 2000-12-06 2003-12-12 Genodyssee Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
KR101993938B1 (ko) * 2011-04-13 2019-06-27 내셔날 리서치 카운실 오브 캐나다 IFNα2로부터의 SAR 인자를 갖는 발현 시스템

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery

Also Published As

Publication number Publication date
TR200003271T2 (tr) 2001-03-21
KR20010052278A (ko) 2001-06-25
WO1999057292A9 (en) 1999-12-16
CZ299418B6 (cs) 2008-07-16
HUP0102517A2 (hu) 2001-11-28
CZ20003705A3 (cs) 2001-04-11
NO20005585D0 (no) 2000-11-06
HUP0102517A3 (en) 2004-06-28
IL139433A0 (en) 2001-11-25
CA2328459A1 (en) 1999-11-11
JP2002513580A (ja) 2002-05-14
CN1309710A (zh) 2001-08-22
AR016264A1 (es) 2001-06-20
EP1075531A1 (en) 2001-02-14
NO20005585L (no) 2001-01-05
WO1999057292A1 (en) 1999-11-11
PL344517A1 (en) 2001-11-05

Similar Documents

Publication Publication Date Title
CA2005016C (en) Dna fragment containing promoter region for human polypeptide chain elongation factor-1.alpha. and expression plasmid containing the dna fragment
Zeng et al. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C
EP1228237A1 (en) Expression vectors, transfection systems, and method of use thereof
AU3788799A (en) Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
Merrill et al. Genetic and physical analysis of the chicken tk gene
WO1999057263A9 (en) Modifying the expression of the fsh beta gene by homologous recombination
CN113544257A (zh) 中国仓鼠卵巢细胞中内源性逆转录病毒的表征及灭活
US5681942A (en) Fanconi Anemia Type C gene
Chan et al. Mouse α-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus
AU3788899A (en) Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
KR20140015999A (ko) 신규 ＭＡＲｓ 및 이를 이용하여 목적 단백질을 생산하는 방법
CN109295000B (zh) 一种多能干细胞形成必需蛋白crept在诱导多能干细胞中的应用
US5952190A (en) cDNA for fanconi anemia complementation group A
EP0369458A2 (en) Bovine metallothionein regulatory region

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted